NorthCoast Asset Management »

Alnylam Pharmaceuticals shares owned by NorthCoast Asset Management

Quarter-by-quarter ownership of Alnylam Pharmaceuticals (ALNY) shares owned by NorthCoast Asset Management from 13F filings

Historical chart of NorthCoast Asset Management investment in Alnylam Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Alnylam Pharmaceuticals held by NorthCoast Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Alnylam Pharmaceuticals by NorthCoast Asset Management

Quarter filed Position value Share count Share price at filing
2021-09-30 $1.4M 7.5k 188.80

More positions owned by NorthCoast Asset Management

Ishares Tr Core S&p 500 Etf (IVV)
Apple Common (AAPL)
Ishares Tr Mbs Fixed Bdfd (MBB)
Ishares Tr Core S&p Mid-cap Etf (IJH)
Unitedhealth Group Common (UNH)
Vaneck Vectors Etf Tr Etf Hg Yld Mun (HYD)
Microsoft Corp Common (MSFT)
Ishares Msci Eurozone (EZU)
Ishares Tr Ishs 5-10yr Invt (IGIB)
Alphabet Class A (GOOGL)
Facebook Class A (META)
Invesco Exchange Traded Fd T S&p 500 Equal Weight (RSP)
Ishares U S Etf Tr It Rt Hdg Hgyl (HYGH)
Amazon Common (AMZN)
American Express Common (AXP)

View all positions for NorthCoast Asset Management

Top funds holding Alnylam Pharmaceuticals

Capital World Investors
FMR
Vanguard Group
BlackRock
Capital Research Global Investors
Wellington Management Company
Baillie Gifford & Co
Capital Research and Management Company - Division 3
Dodge & Cox
State Street Corporation
T. Rowe Price Associates
T. Rowe Price Investment Management
Jpmorgan Chase & Co
Geode Capital Management
American Century Companies

View all funds holding Alnylam Pharmaceuticals